Clinical Trial Update: CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia [Phase 4]

View source ↗

Summary

CARE, a Phase 4 trial sponsored by the University of British Columbia, evaluating treatment for the most severely ill patients with schizophrenia, has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Snippet

Sponsor: University of British Columbia | Conditions: Psychosis, Schizophrenia | Phase 4 | Status: COMPLETED